Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 3, 2013, Pages 407-412

  Wang, M C ^a,b   Lin, W H ^a,b   Tseng, C C ^a   Wu, A B ^a   Teng, C H ^b   Yan, J J ^a   Wu, J J ^c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; K1 CAPSULE ANTIGEN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIAL CAPSULE; BACTERIAL GENE; BACTERIAL PERITONITIS; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; INTESTINE PERFORATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUA GENE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; SPECIES COMPARISON; TAIWAN;

ADULT; AGED; BACTERIAL CAPSULES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PERITONITIS; PHYLOGENY; PREVALENCE; SURVIVAL ANALYSIS; TAIWAN; VIRULENCE FACTORS;

EID: 84874114145     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1757-9     Document Type: Article

References (28)

1. Lata J, Stiburek O, Kopacova M (2009) Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol 15(44):5505-5510
2. Cheong HS, Kang CI, Lee JA, Moon SY, Joung MK, Chung DR, Koh KC, Lee NY, Song JH, Peck KR (2009) Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 48(9):1230-1236
3. Lee JM, Han KH, Ahn SH (2009) Ascites and spontaneous bacterial peritonitis: an Asian perspective. J Gastroenterol Hepatol 24(9):1494-1503
4. Cǎruntu FA, Benea L (2006) Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J Gastrointest Liver Dis 15(1):51-56
5. Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, Marcon E, Valla D, Moreau R, Nicolas-Chanoine MH (2010) Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 48:2709-2714
6. Bert F, Panhard X, Johnson J, Lecuyer H, Moreau R, Le Grand J, Johnston B, Sinègre M, Valla D, Nicolas-Chanoine MH (2008) Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis. Clin Microbiol Infect 14(11):1034-1040
7. Song KH, Jeon JH, Park WB, Park SW, Kim HB, Oh MD, Lee HS, Kim NJ, Choe KW (2009) Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis 9:41
8. Wilson JW, Schurr MJ, LeBlanc CL, Ramamurthy R, Buchanan KL, Nickerson CA (2002) Mechanisms of bacterial pathogenicity. Postgrad Med J 78(918):216-224
9. Scholl D, Adhya S, Merril C (2005) Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl Environ Microbiol 71(8):4872-4874
10. Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL, Cross AS (1992) The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest 90(3):897-905
11. Johnson JR, Oswald E, O'Bryan TT, Kuskowski MA, Spanjaard L (2002) Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis 185(6):774-784
12. Bonacorsi S, Houdouin V, Mariani-Kurkdjian P, Mahjoub-Messai F, Bingen E (2006) Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol 44(3):1156-1158
13. Soriano G, Coll P, Guarner C, Such J, Sánchez F, Prats G, Vilardell F (1995) Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis. Hepatology 21(3):668-673
14. Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32(1):142-153
15. Durand F, Valla D (2005) Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 42(Suppl 1):S100-S107
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33(2):464-470
17. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. CLSI, Wayne
18. Ferraro MJ, Gilligan PH, Saubolle MA, Weissfeld AS (1995) Bacteriology. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 6th edn. ASM Press, Washington, DC, pp 246-262
19. Wang MC, Tseng CC, Wu AB, Huang JJ, Sheu BS, Wu JJ (2009) Different roles of host and bacterial factors in Escherichia coli extra-intestinal infections. Clin Microbiol Infect 15(4):372-379
20. Tseng CC, Wu JJ, Liu HL, Sung JM, Huang JJ (2002) Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli. Am J Kidney Dis 39(4):744-752
21. Robbins JB, McCracken GH Jr, Gotschlich EC, Orskov F, Orskov I, Hanson LA (1974) Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 290(22):1216-1220
22. McCracken GH Jr, Sarff LD, Glode MP, Mize SG, Schiffer MS, Robbins JB, Gotschlich EC, Orskov I, Orskov F (1974) Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet 2(7875):246-250
23. Pitt J (1979) Virulence of Escherichia coli K1 in adults. J Infect Dis 139(1):106-108
24. Marklund BI, Tennent JM, Garcia E, Hamers A, Båga M, Lindberg F, Gaastra W, Normark S (1992) Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol 6(16):2225-2242
25. Jauréguy F, Carbonnelle E, Bonacorsi S, Clec'h C, Casassus P, Bingen E, Picard B, Nassif X, Lortholary O (2007) Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin Microbiol Infect 13(9):854-862
26. Hui CY, Guo Y, He QS, Peng L, Wu SC, Cao H, Huang SH (2010) Escherichia coli outer membrane protease OmpT confers resistance to urinary cationic peptides. Microbiol Immunol 54(8):452-459
27. Stumpe S, Schmid R, Stephens DL, Georgiou G, Bakker EP (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 180(15):4002-4006
28. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, Ogawa O, Yamamoto S (2003) Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 170(6 Pt 1):2490-2493